These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 38011322)
1. Exploration of Thermally Activated Delayed Fluorescence (TADF)-Based Photoredox Catalyst To Establish the Mechanisms of Action for Photodynamic Therapy. Zhang J; Ma J; Zhang S; Lou X; Ding Y; Li Y; Xu M; Xie X; Jiao X; Dou X; Wang X; Tang B ACS Nano; 2023 Dec; 17(23):23430-23441. PubMed ID: 38011322 [TBL] [Abstract][Full Text] [Related]
2. Recent Progress in Thermally Activated Delayed Fluorescence Photosensitizers for Photodynamic Therapy. Li Z; Lu J; Li X Chemistry; 2024 Jul; 30(40):e202401001. PubMed ID: 38742479 [TBL] [Abstract][Full Text] [Related]
3. Near-Infrared Thermally Activated Delayed Fluorescence Nanoparticle: A Metal-Free Photosensitizer for Two-Photon-Activated Photodynamic Therapy at the Cell and Small Animal Levels. Fang F; Yuan Y; Wan Y; Li J; Song Y; Chen WC; Zhao D; Chi Y; Li M; Lee CS; Zhang J Small; 2022 Feb; 18(6):e2106215. PubMed ID: 35018711 [TBL] [Abstract][Full Text] [Related]
4. Intrinsically Cancer-Mitochondria-Targeted Thermally Activated Delayed Fluorescence Nanoparticles for Two-Photon-Activated Fluorescence Imaging and Photodynamic Therapy. Zhang J; Fang F; Liu B; Tan JH; Chen WC; Zhu Z; Yuan Y; Wan Y; Cui X; Li S; Tong QX; Zhao J; Meng XM; Lee CS ACS Appl Mater Interfaces; 2019 Nov; 11(44):41051-41061. PubMed ID: 31602976 [TBL] [Abstract][Full Text] [Related]
5. Delayed fluorescence from a zirconium(IV) photosensitizer with ligand-to-metal charge-transfer excited states. Zhang Y; Lee TS; Favale JM; Leary DC; Petersen JL; Scholes GD; Castellano FN; Milsmann C Nat Chem; 2020 Apr; 12(4):345-352. PubMed ID: 32203439 [TBL] [Abstract][Full Text] [Related]
6. From Low to No O Li M; Xu Y; Peng X; Kim JS Acc Chem Res; 2022 Nov; 55(22):3253-3264. PubMed ID: 36323625 [TBL] [Abstract][Full Text] [Related]
7. Integration of TADF Photosensitizer as "Electron Pump" and BSA as "Electron Reservoir" for Boosting Type I Photodynamic Therapy. Chen W; Wang Z; Tian M; Hong G; Wu Y; Sui M; Chen M; An J; Song F; Peng X J Am Chem Soc; 2023 Apr; 145(14):8130-8140. PubMed ID: 37001012 [TBL] [Abstract][Full Text] [Related]
8. A dual-targeted theranostic photosensitizer based on a TADF fluorescein derivative. Liu Z; Shi W; Hong G; Chen W; Song B; Peng X; Xiong X; Song F J Control Release; 2019 Sep; 310():1-10. PubMed ID: 31381942 [TBL] [Abstract][Full Text] [Related]
9. Photoredox catalysis may be a general mechanism in photodynamic therapy. Li M; Xu Y; Pu Z; Xiong T; Huang H; Long S; Son S; Yu L; Singh N; Tong Y; Sessler JL; Peng X; Kim JS Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2210504119. PubMed ID: 35969782 [TBL] [Abstract][Full Text] [Related]
10. A Dual-Nanozyme-Catalyzed Cascade Reactor for Enhanced Photodynamic Oncotherapy against Tumor Hypoxia. Chen M; Song J; Zhu J; Hong G; An J; Feng E; Peng X; Song F Adv Healthc Mater; 2021 Nov; 10(21):e2101049. PubMed ID: 34494723 [TBL] [Abstract][Full Text] [Related]
11. Nitroreductase-Activatable Theranostic Molecules with High PDT Efficiency under Mild Hypoxia Based on a TADF Fluorescein Derivative. Liu Z; Song F; Shi W; Gurzadyan G; Yin H; Song B; Liang R; Peng X ACS Appl Mater Interfaces; 2019 May; 11(17):15426-15435. PubMed ID: 30945838 [TBL] [Abstract][Full Text] [Related]
12. pH-Responsive Amphiphilic Triblock Fluoropolymers as Assemble Oxygen Nanoshuttles for Enhancing PDT against Hypoxic Tumor. Zhang JA; Haddleton D; Wilson P; Zhu LH; Dai CY; Zhao LL Bioconjug Chem; 2024 Mar; 35(3):400-411. PubMed ID: 38366969 [TBL] [Abstract][Full Text] [Related]
13. Self-Assembled Platinum Supramolecular Metallacycles Based on a Novel TADF Photosensitizer for Efficient Cancer Photochemotherapy. Lv S; Miao Y; Zheng D; Li X; Liu D; Song F Mol Pharm; 2021 Mar; 18(3):1229-1237. PubMed ID: 33427472 [TBL] [Abstract][Full Text] [Related]
14. Polymer Dots with Delayed Fluorescence and Tunable Cellular Uptake for Photodynamic Therapy and Time-Gated Imaging. Luppi BT; Primrose WL; Hudson ZM Angew Chem Int Ed Engl; 2024 Apr; 63(17):e202400712. PubMed ID: 38439710 [TBL] [Abstract][Full Text] [Related]
15. Constructing Heavy-Atom-Free Photosensitizers for Hypoxic Tumor Phototherapy Based on Donor-Excited Photoinduced Electron-Transfer-Driven Type-I and Type-II Mechanisms. Miao J; Yao G; Huo Y; Wang B; Zhao W; Guo W ACS Appl Mater Interfaces; 2024 Aug; 16(31):40428-40443. PubMed ID: 39042585 [TBL] [Abstract][Full Text] [Related]
16. Programmable therapeutic nanoscale covalent organic framework for photodynamic therapy and hypoxia-activated cascade chemotherapy. He H; Du L; Xue H; Wu J; Shuai X Acta Biomater; 2022 Sep; 149():297-306. PubMed ID: 35811069 [TBL] [Abstract][Full Text] [Related]
17. Reactive Reductive Species Participating Photodynamic Therapy for Cancer Treatment. Peng J; Feng F Chemistry; 2024 Jan; 30(1):e202302842. PubMed ID: 37750352 [TBL] [Abstract][Full Text] [Related]
19. Strategic Design of Conquering Hypoxia in Tumor for Advanced Photodynamic Therapy. Zhang C; Hu X; Jin L; Lin L; Lin H; Yang Z; Huang W Adv Healthc Mater; 2023 Sep; 12(24):e2300530. PubMed ID: 37186515 [TBL] [Abstract][Full Text] [Related]
20. Recent Advances in Hypoxia-Overcoming Strategy of Aggregation-Induced Emission Photosensitizers for Efficient Photodynamic Therapy. Chen H; Wan Y; Cui X; Li S; Lee CS Adv Healthc Mater; 2021 Dec; 10(24):e2101607. PubMed ID: 34674386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]